Table 2 Relationship between Gal1 (ng/ml) serum levels and disease activity or disability.
From: Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
Disease activity | ||
|---|---|---|
β Coeff. (95 % CI) | p value | |
DAS28 | 0.51 (− 0.32 to 1.36) | 0.231 |
Female gender | 2.15 (− 1.5 to 5.8) | 0.256 |
Age (years) | ||
< 45 | Reference | – |
45–65 | 4.68 (1.40 to 7.95) | 0.005 |
> 65 | 2.87 (− 0.64 to 6.39) | 0.109 |
Time of frozen storage (months) | − 0.03 (− 0.06 to − 0.01) | 0.002 |
Disability | ||
|---|---|---|
β Coeff. (95 % CI) | p value | |
HAQ | 1.26 (− 0.62 to 3.15) | 0.189 |
Female gender | 1.87 (− 1.93 to 5.67) | 0.336 |
Age (years) | ||
< 45 | Reference | – |
45–65 | 4.55 (1.29 to 7.81) | 0.006 |
> 65 | 2.54 (− 1.06 to 6.14) | 0.167 |
Time of frozen storage (months) | − 0.03 (− 0.06 to − 0.01) | 0.005 |
